Suven Life Sciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: SUVEN | BSE: 530239
₹128.72 
-2.69 (-2.05 %)
Last Updated: 04 Apr 2025 03:49 PM
BULLISH
Overview
Open (₹) 131.00
High (₹) 139.90
Low (₹) 128.00
Prev. Close (₹) 131.41
Volume 10,38,090
VWAP (₹) 104.12
ROCE (%) -41.77
Industry P/E 61.88
TTM P/E -19.59
P/B Ratio 10.40
Market Cap (₹) Cr.2,807.04
Dividend Yield (%)--
EPS (₹) -4.82
ROE-38.93%
Sales Growth (%) -13.64
Profit Growth (%)-11.15
Day Range
139.90139.90
52 Week Range
83.27169.00
Historical Returns
Returns (6M)
-4.44 %
Returns (1Y)
14.72 %
Returns (3Y)
43.82 %
Returns (5Y)
523.64 %
Returns (6M)
-4.44 %
Returns (1Y)
14.72 %
Returns (3Y)
43.82 %
Returns (5Y)
523.64 %
SWOT Analysis
- Company with no debt
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BULLISHRSI 41.73
MFI 27.30
ATR 7.04
Commodity Channel Index -154.53
ROC125 -27.22
ROC21 -10.50
Williams %R -94.51
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 106.86 | 109.56 | 111.74 | 104.68 | 101.98 | 99.80 | 97.10 |
| Week Ago | 120.19 | 122.78 | 124.56 | 118.41 | 115.82 | 114.04 | 111.45 |
| Month Ago | 120.56 | 125.68 | 128.46 | 117.78 | 112.66 | 109.88 | 104.76 |
EMA & SMA
128.72
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 113.61
9 Day 113.61
10 Day 113.95
12 Day 116.24
14 Day 118.40
20 Day 121.81
26 Day 120.46
50 Day 126.42
100 Day 128.58
200 Day 127.18
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 11 Jan, 2024 | ₹121.70 | 14,28,543 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 11 Jan, 2024 | ₹121.82 | 14,28,543 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 13 Sept, 2023 | ₹78.20 | 15,34,944 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 13 Sept, 2023 | ₹78.12 | 15,34,944 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 23 Apr, 2021 | ₹109.97 | 6,40,960 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 23 Apr, 2021 | ₹109.64 | 6,40,960 | NSE |
| ALPHA LEON ENTERPRISES LLP | bulk | Sell | 17 Dec, 2020 | ₹105.08 | 6,27,462 | NSE |
| ALPHA LEON ENTERPRISES LLP | bulk | Buy | 17 Dec, 2020 | ₹104.94 | 6,56,474 | NSE |
| KATKAR SANJAY | bulk | Buy | 18 Sept, 2020 | ₹56.27 | 6,88,893 | NSE |
| ALPHA LEON ENTERPRISES LLP | bulk | Sell | 21 Apr, 2020 | ₹32.17 | 7,61,598 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 May, 2024 | SUDHARANI JASTI | Acquisition | ₹ | 15,25,535 | NSE |
| 29 Mar, 2022 | Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of the Jasti Family Trust | Acquisition | ₹81.57 | 1,81,00,000 | NSE |
| 06 Apr, 2021 | Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of the Jasti Family Trust | Acquisition | ₹81.57 | 1,81,00,000 | NSE |
| 02 Sept, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹49.30 | 15,000 | NSE |
| 31 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹53.81 | 10,000 | NSE |
| 27 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹52.72 | 20,000 | NSE |
| 24 Aug, 2020 | VENKATA RAMUDU JASTHI | Acquisition | ₹50.01 | 20,000 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 24 Jun, 2022 | Rights issue of equity shares of Re. 1/- in the ratio of 1:2 @ premium of Rs. 54/-. | 17 Oct, 2022 | 18 Oct, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 02 Apr, 2025 | BSE India | Certificate in terms of Reg. 74 (5) of SEBI (DP) Regulations |
| 02 Apr, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
| 26 Mar, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about Action(s) initiated or orders passed |
| 26 Mar, 2025 | NSE India | SUVEN LIFE SCIENCES LIMITED has informed the Exchange about Closure of Trading Window |
| 26 Mar, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 21 Mar, 2025 | BSE India | Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), 2015 |
| 21 Mar, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about Action(s) initiated or orders passed |
| 26 Feb, 2025 | NSE India | Suven Life Sciences Limited has informed the Exchange about Action(s) initiated or orders passed |
| 03 Feb, 2025 | NSE India | Report of the Monitoring Agency with respect to utilization of proceeds of the Rights Issue for the quarter ended 31st December, 2024. |
| 03 Feb, 2025 | BSE India | Report of the Monitoring Agency for quarter ended December 31, 2024 regarding utilisation of proceeds of the rights issue |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 17 Jan, 2025 | 24 Jan, 2025 |
| Quarterly Results | -- | 22 Oct, 2024 | 29 Oct, 2024 |
| Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
| Audited Results | -- | 30 Apr, 2024 | 06 May, 2024 |
| Quarterly Results | -- | 24 Jan, 2024 | 30 Jan, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 04 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results | -- | 04 May, 2023 | 09 May, 2023 |
| Quarterly Results | -- | 26 Jan, 2023 | 02 Feb, 2023 |
| Quarterly Results | -- | 04 Nov, 2022 | 10 Nov, 2022 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 70.27% | 69.57% | 69.57% | 60% | 60% |
| Foreign Institutions + | 0.33% | 0.54% | 0.46% | 0.52% | 1.05% |
| Domestic Institutions + | 1.05% | 0.12% | 0.11% | 0.44% | 0.67% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 28.35% | 29.77% | 29.86% | 39.04% | 38.28% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Suven Life Sciences
Suven Life Sciences is a Public Limited Listed company incorporated on 09/03/1989 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1989PLC009713 and registration number is 009713. Currently Company is involved in the business activities of Other professional, scientific and technical activities. Company’s Total Operating Revenue is Rs. 11.69 Cr. and Equity Capital is Rs. 21.81 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1989
Managing Director
Mr. Venkateswarlu Jasti
NSE Symbol
SUVEN
Suven Life Sciences Management
| Name | Designation |
|---|---|
| Mr. Venkateswarlu Jasti | Chairman & Managing Director |
| Mrs. Sudharani Jasti | Whole Time Director |
| Prof. Seyed E Hasnain | Director |
| Mr. Santanu Mukherjee | Director |
| Mrs. J A S Padmaja | Director |
| Dr. Vajja Sambasiva Rao | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Syngene International | ₹29,169.84 | ₹724.65  ₹747.15(-3.01%) | ₹608.000 - ₹960.000 |
| Sun Pharma Advanced Research Company | ₹4,723.09 | ₹145.54 ₹150.00(-2.97%) | ₹109.200 - ₹474.000 |
| Suven Life Sciences | ₹2,807.04 | ₹128.72 ₹131.41(-2.05%) | ₹83.270 - ₹169.000 |
| Vimta Labs | ₹2,055.47 | ₹924.45 ₹1,092.35(-15.37%) | ₹420.000 - ₹1,183.000 |
| Choksi Laboratories | ₹82.82 | ₹118.90 ₹123.40(-3.65%) | ₹46.010 - ₹142.400 |
FAQs on Suven Life Sciences
What is the share price of Suven Life Sciences?
The share price of Suven Life Sciences on 04 Apr, 2025 is ₹ 128.72.
What is 52W high and 52W low share price of Suven Life Sciences?
The highest and lowest 52W share prices of Suven Life Sciences are ₹ 169.000 and ₹ 83.270
What is the market cap of Suven Life Sciences?
The market capitalization of Suven Life Sciences as of 04 Apr, 2025 is ₹ 2,807.04 Crores
What is the P/E ratio of Suven Life Sciences?
The current P/E ratio of Suven Life Sciences as of 04 Apr, 2025 is 61.88
What is the PB ratio of Suven Life Sciences?
The PB ratio of Suven Life Sciences as of 04 Apr, 2025 is 10.40
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)